Lexaria Bioscience (LEXX) Earnings Date & Reports

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LEXX is expected to report earnings to rise 6.25% to -17 cents per share on April 15

Lexaria Bioscience LEXX Stock Earnings Reports

Q1'25

Est.

$-0.17

Q4'24

Missed

by $0.08

Q3'24

Missed

by $0.02

Q2'24

Est.

$-0.13

Q1'24

Beat

by $0.02

The last earnings report on January 15 showed earnings per share of -15 cents, missing the estimate of -7 cents. With 34.17K shares outstanding, the current market capitalization sits at 29.31M.

View a ticker or compare two or three

Compare

LEXX